BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32179174)

  • 1. Association of 5'UTR polymorphism of secretory phospholipase A2 group IIA (PLA2G2A) gene with prostate cancer metastasis.
    Ozturk K; Onal MS; Efiloglu O; Nikerel E; Yildirim A; Telci D
    Gene; 2020 Jun; 742():144589. PubMed ID: 32179174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of PLA2G2A single nucleotide polymorphisms with type IIa secretory phospholipase A2 level but not its activity in patients with stable coronary heart disease.
    Shuvalova YA; Khasanova ZB; Kaminnaya VI; Samoilova EV; Korotaeva AA; Rubanovich AV; Kaminnyi AI
    Gene; 2015 Jun; 564(1):29-34. PubMed ID: 25794429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of single nucleotide polymorphisms in the prostaglandin-endoperoxide synthase 2 (PTGS2) and phospholipase A₂ group IIA (PLA2G2A) genes with susceptibility to esophageal squamous cell carcinoma.
    Liu F; Wei WQ; Cormier RT; Zhang ST; Qiao YL; Li XQ; Zhu ST; Zhai YC; Peng XX; Yan YX; Wu LJ; He D; He Y
    Asian Pac J Cancer Prev; 2014; 15(4):1797-802. PubMed ID: 24641411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
    Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
    Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of two PLA2G2A variants associated with secretory phospholipase A2-IIA levels.
    Exeter HJ; Folkersen L; Palmen J; Franco-Cereceda A; Cooper JA; Kalea AZ; Hooft FV; Eriksson P; Humphries SE; Talmud PJ
    PLoS One; 2012; 7(7):e41139. PubMed ID: 22879865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLA2G2A polymorphisms are associated with metabolic syndrome and type 2 diabetes mellitus. Results from the genetics of atherosclerotic disease Mexican study.
    Monroy-Muñoz IE; Angeles-Martinez J; Posadas-Sánchez R; Villarreal-Molina T; Alvarez-León E; Flores-Dominguez C; Cardoso-Saldaña G; Medina-Urrutia A; Juárez-Rojas JG; Posadas-Romero C; Alarcon GV
    Immunobiology; 2017 Oct; 222(10):967-972. PubMed ID: 27608594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of group IIA phospholipase A2 is an independent predictor of favorable outcome for patients with gastric cancer.
    Wang X; Huang CJ; Yu GZ; Wang JJ; Wang R; Li YM; Wu Q
    Hum Pathol; 2013 Oct; 44(10):2020-7. PubMed ID: 23664539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
    Srivastava P; Kapoor R; Mittal RD
    Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentration of interleukin-35 and its association with tumor stages and FOXP3 gene polymorphism in patients with prostate cancer.
    Chatrabnous N; Ghaderi A; Ariafar A; Razeghinia MS; Nemati M; Jafarzadeh A
    Cytokine; 2019 Jan; 113():221-227. PubMed ID: 30057362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of caspases with an increased prostate cancer risk in north Indian population.
    Mittal RD; Mittal T; Singh AK; Mandal RK
    DNA Cell Biol; 2012 Jan; 31(1):67-73. PubMed ID: 21668377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Autophagy Gene ATG16L1 Polymorphism with Human Prostate Cancer and Bladder Cancer in Turkish Population.
    Budak Diler S; Aybuğa F
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2625-2630. PubMed ID: 30256070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population.
    Albayrak S; Cangüven O; Göktaş C; Aydemir H; Köksal V
    Urol Int; 2007; 79(4):312-5. PubMed ID: 18025848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphism in the CYP17 gene is associated with prostate cancer risk.
    Gsur A; Bernhofer G; Hinteregger S; Haidinger G; Schatzl G; Madersbacher S; Marberger M; Vutuc C; Micksche M
    Int J Cancer; 2000 Aug; 87(3):434-7. PubMed ID: 10897051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insertion/deletion polymorphism of IL1A 3'-UTR associated with the susceptibility of prostate cancer ].
    Liao H; Zhang L; Cheng P; Pu Y; Wu Y; Li Z; Xiao YM; Yang SK
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):956-9. PubMed ID: 25571723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.
    Mirtti T; Laine VJ; Hiekkanen H; Hurme S; Rowe O; Nevalainen TJ; Kallajoki M; Alanen K
    APMIS; 2009 Mar; 117(3):151-61. PubMed ID: 19245588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between DNA repair gene XRCC1 Arg399Gln polymorphism and susceptibility to prostate cancer in the Han population in Jiangsu and Anhui].
    Xu Z; Qian LX; Hua LX; Wang XR; Yang J; Zhang W; Wu HF
    Zhonghua Nan Ke Xue; 2007 Apr; 13(4):327-31. PubMed ID: 17491266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
    Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T
    Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3.
    Safarinejad MR; Shafiei N; Safarinejad S
    Growth Horm IGF Res; 2011 Jun; 21(3):146-54. PubMed ID: 21536469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline variations of apurinic/apyrimidinic endonuclease 1 (APEX1) detected in female breast cancer patients.
    Ali K; Mahjabeen I; Sabir M; Baig RM; Zafeer M; Faheem M; Kayani MA
    Asian Pac J Cancer Prev; 2014; 15(18):7589-95. PubMed ID: 25292033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.